Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00302016
Expanded Access Status : No longer available
First Posted : March 13, 2006
Last Update Posted : August 26, 2011
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )

No Study Results Posted on for this Study
  Expanded Access Status : No longer available
  Actual Primary Completion Date : November 2008
  Study Completion Date : No date given